Hospira Financial Statements
Hospira Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Hospira Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,436.2 | 2,688.5 | 2,626.7 |
| Gross Profit ($ mil.) | 1,173.9 | 939.2 | 849.1 |
| Operating Income ($ mil.) | 302.6 | 339.6 | 336.6 |
| Total Net Income ($ mil.) | 136.8 | 237.7 | 235.6 |
| Diluted EPS (Net Income) | 0.85 | 1.48 | 1.46 |
Hospira Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 901.6 | 888.7 | 946.1 |
| Gross Profit ($ mil.) | 329.4 | 314.0 | 338.6 |
| Operating Income ($ mil.) | 117.7 | 111.7 | 114.0 |
| Total Net Income ($ mil.) | 69.1 | 65.4 | 76.1 |
| Diluted EPS (Net Income) | 0.42 | 0.41 | 0.47 |
Hospira Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.78 | 3.75 | 1.56 |
| Price/Earnings Ratio | 23.39 | 16.34 | 15.82 |
| Price/Book Ratio | 3.14 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | 11.34 | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Hospira Financial Ratios
Hospira Competitive Intelligence
| APP Pharmaceuticals | B. Braun Medical | Baxter | |
|---|---|---|---|
| Annual Sales ($ mil.) | 647.4 | 345.2 | 11,263.0 |
| Employees | -- | 4,099 | 46,000 |
| Market Cap ($ mil.) | 3,850.4 | -- | 43,566.0 |
Competitive Landscape
